B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Mefruside

75 PubMed studies analyzed · 10 RCTs · Evidence Score: 45.5

Research Domains

Mefruside has been studied across 13 research domains including ❤️ Cardiovascular, 🫘 Kidney, 🧠 Focus & Attention, 🔥 Metabolic, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 64% of studies addressing this area.

Loading evidence profile...

This evidence profile for Mefruside is generated deterministically from 75 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.